Skip main navigation

Weekly Reflection


This week, we have learnt the therapeutic classification of biotechnology products; currently marketed rDNA products and their indications; currently marketed MAb products and their indications; and principles associated with handling, storage and administration of biotechnology products.

Here are some key points for you to review what you have learnt this week. There is no need to answer them all. You could use these to check the gist of this week.

  1. Stay current with new biologics approval by consulting with this [web links] (

  2. To be able to name at least one product for each of the following therapeutic classes of biologics: Anticoagulant/Coagulant, Antisense, Colony Stimulating Factor, Erythropoietin, Human Growth Hormone, Interferons, Interleukins, Reverse Transcriptase Inhibitors, Tissue Necrosis Factors and Tyrosine Kinase Inhibitors

  3. To be ready for opportunities to play multiple roles as a consultant to the physician, as an advisor to the patient and as an advocate for the under-served. Of particular importance is to assist with product selection, genetic screening for efficacy/safety, and product accessibility and pricing (particularly in the case of Biosimilars).

This article is from the free online

Pharmacotherapy: Understanding Biotechnology Products

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education